|Ask||3.85 x 600|
|Day's Range||3.55 - 3.64|
|52 Week Range||2.41 - 7.39|
|PE Ratio (TTM)||-0.81|
|Earnings Date||Sep 18, 2017 - Sep 22, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||2.00|
LONDON, UK / ACCESSWIRE / July 12, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Cesca Therapeutics Inc. (NASDAQ: KOOL ), following which we have ...
Companies in the News are: HCOM,CBB,KOOL,MYCC,APO,CETV
Rancho Cordova-based regenerative medicine company Cesca Therapeutics Inc. is acquiring SynGen Inc., a Sacramento-based developer of cellular processing technology. Under the deal, SynGen's assets will be folded into Cesca (KOOL) subsidiary Thermogenesis Corp., Cesca said in a news release Monday. SynGen shareholders will receive $1 million in cash and 20 percent of ThermoGenesis's common stock.